21. Clifford K., Flanagan A.M., Regan L. Endometrial CD56+natural killer cells in women with recurrent miscarriage: a histomorphometric study. Hum Reprod. 1999; 14: 2727–30.
22. Raghupathy R., Makhseed M., Azizieh F., Omu A., Gupta M., Farhat R. Cytokine production by maternal lymphocytes during normal human pregnancy and in unexplained recurrent spontaneous abortion. Hum Reprod. 2000; 15: 713–8.
23. Ng S.C., Gilman-Sachs A., Thaker P., Beaman K.D., Beer A.E., Kwak-Kim J. Expression of intracellular Th1 and Th2 cytokines in women with recurrent spontaneous abortion, implantation failures after IVF/ET or normal pregnancy. Am J Reprod Immunol. 2002; 48: 77–86.
24. Grandone E., Colaizzo D., Lo Bue A., Checola M.G., Cittadini E., Margaglione M. Inherited thrombophilia and in vitro fertilization implantation failure. Fertil Steril. 2001; 76: 201–2.
25. Azem F., Many A., Ben Ami I., et al. Increased rates of thrombophilia in women with repeated IVF failures. Hum Reprod. 2004; 19: 368–70.
26. Winter E., Wang J., Davies M.J., Norman R. Early pregnancy loss following assisted reproductive technology treatment. Hum Reprod. 2002; 17: 3220–3.
27. Venners S.A., Wang X., Chen C., et al. Paternal smoking and pregnancy loss: a prospective study using a biomarker of pregnancy. Am J Epidemiol. 2004; 159: 993–1001.
28. Chen L.W., Wu Y., Neelakantan N., Chong M.F., Pan A., van Dam R.M. Maternal caffeine intake during pregnancy and risk of pregnancy loss: a categorical and dose-response meta-analysis of prospective studies. Public Health Nutr. 2016; 19: 1233–44.
29. Kesmodel U., Wisborg K., Olsen S.F., Henriksen T.B., Secher N.J. Moderate alcohol intake in pregnancy and the risk of spontaneous abortion. Alcohol Alcohol. 2002; 37: 87–92.
30. Boots C.E., Bernardi L.A., Stephenson M.D. Frequency of euploid miscarriage is increased in obese women with recurrent early pregnancy loss. Fertil Steril. 2014; 102: 455–9.
31. Lok I.H., Neugebauer R. Psychological morbidity following miscarriage. Best Pract Res Clin Obstet Gynaecol. 2007; 21: 229–47.
32. Kolte A.M., Olsen L.R., Mikkelsen E.M., Christiansen O.B., Nielsen H.S. Depression and emotional stress is highly prevalent among women with recurrent pregnancy loss. Hum Reprod. 2015; 30: 777–82.
33. Craig M., Tata P., Regan L. Psychiatric morbidity among patients with recurrent miscarriage. J Psychosom Obstet Gynaecol. 2002; 23: 157–64.
34. Li W., Newell-Price J., Jones G.L., Ledger W.L., Li T.C. Relationship between psychological stress and recurrent miscarriage. Reprod Biomed Online. 2012; 25: 180–9.
35. Sugiura-Ogasawara M., Furukawa T.A., Nakano Y., Hori S., Aoki K., Kitamura T. Depression as a potential causal factor in subsequent miscarriage in recurrent spontaneous aborters. Hum Reprod. 2002; 17: 2580–4.
36. Cicinelli E., Resta L., Nicoletti R., et al. Detection of chronic endometritis at fluid hysteroscopy. J Minim Invasive Gynecol. 2005; 12: 514–8.
37. Kuroda K., Takamizawa S., Motoyama H., et al. Analysis of the therapeutic effects of hysteroscopic polypectomy with and without doxycycline treatment on chronic endometritis with endometrial polyps. Am J Reprod Immunol. 2021; 85: e13392.
38. Kuroda K., Horikawa T., Moriyama A., et al. Impact of chronic endometritis on endometrial receptivity analysis results and pregnancy outcomes. Immun Inflamm Dis. 2020; 8: 650–8.
39. Ikemoto Y., Kuroda K., Nakagawa K., et al. Vitamin D regulates maternal T-helper cytokine production in infertile women. Nutrients. 2018; 10: 902.
40. Nakagawa K., Kwak-Kim J., Ota K., et al. Immunosuppression with tacrolimus improved reproductive outcome of women with repeated implantation failure and elevated peripheral blood Th1/Th2 cell ratios. Am J Reprod Immunol. 2015; 73: 353–61.
41. Ross A.C., Manson J.E., Abrams S.A., et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: What clinicians need to know. J Clin Endocrinol Metab. 2011; 96: 53–8.
42. Nakagawa K., Kwak-Kim J., Kuroda K., Sugiyama R., Yamaguchi K. Immunosuppressive treatment using tacrolimus promotes pregnancy outcome in infertile women with repeated implantation failures. Am J Reprod Immunol. 2017; 78: e12682.
43. Csapo A.I., Pulkkinen M.O., Wiest W.G. Effects of luteectomy and progesterone replacement therapy in early pregnant patients. Am J Obstet Gynecol. 1973; 115: 759–65.
44. Gellersen B., Brosens J.J. Cyclic decidualization of the human endometrium in reproductive health and failure. Endocr Rev. 2014; 35: 851–905.
45. Teklenburg G., Salker M., Heijnen C., Macklon N.S., Brosens J.J. The molecular basis of recurrent pregnancy loss: impaired natural embryo selection. Mol Hum Reprod. 2010; 16: 886–95.
46. Wilcox A.J., Baird D.D., Wenberg C.R. Time of implantation of the conceptus and loss of pregnancy. N Engl J Med. 1999; 340: 1796–9.
47. Segawa T., Kuroda T., Kato K., et al. Cytogenetic analysis of the retained products of conception after missed abortion following blastocyst transfer: a retrospective, large-scale, single-centre study. Reprod Biomed Online. 2017; 34: 203–10.
48. Simon A.L., Kiehl M., Fischer E., et al. Pregnancy outcomes from more than 1,800 in vitro fertilization cycles with the use of 24-chromosome single-nucleotide polymorphism-based preimplantation genetic testing for aneuploidy. Fertil Steril. 2018; 110: 113–21.
49. Franasiak J.M., Forman E.J., Hong K.H., et al. The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening. Fertil Steril. 2014; 101: 656–63.e51.
50. Chen T.H., Chang S.P., Tsai C.F., Juang K.D. Prevalence of depressive and anxiety disorders in an assisted reproductive technique clinic. Hum Reprod. 2004; 19: 2313–8.
51. Lynch C.D., Sundaram R., Maisog J.M., Sweeney A.M., Buck Louis G.M. Preconception stress increases the risk of infertility: results from a couple-based prospective cohort study-the LIFE study. Hum Reprod. 2014; 29: 1067–75.
52. Domar A.D., Clapp D., Slawsby E.A., Dusek J., Kessel B., Freizinger M. Impact of group psychological interventions on pregnancy rates in infertile women. Fertil Steril. 2000; 73: 805–11.
53. Gourounti K., Anagnostopoulos F., Vaslamatzis G. The relation of psychological stress to pregnancy outcome among women undergoing in-vitro fertilization and intracytoplasmic sperm injection. Women Health. 2011; 51: 321–39.
54. Maes M., Song C., Lin A., et al. The effects of psychological stress on humans: Increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. Cytokine. 1998; 10: 313–8.
55. Kuroda K., Nakagawa K., Horikawa T., et al. Increasing number of implantation failures and pregnancy losses associated with elevated Th1/Th2 cell ratio. Am J Reprod Immunol. 2021; 86: e13429.
56. de Ziegler D., Frydman R.F. Recurrent pregnancy losses, a lasting cause of infertility. Fertil Steril. 2021; 115: 531–2.
57. Nakagawa K., Kwak-Kim J., Hisano M., et al. Obstetric and perinatal outcome of the women with repeated implantation failures or recurrent pregnancy losses who received pre- and post-conception tacrolimus treatment. Am J Reprod Immunol. 2019; 82: e13142.
58. Nakagawa K., Kuroda K., Sugiyama R., Yamaguchi K. After 12 consecutive miscarriages, a patient received immunosuppressive treatment and delivered an intact baby. Reprod Med Biol. 2017; 16: 297–301.
59. Kimura F., Takebayashi A., Ishida M., et al. Review: Chronic endometritis and its effect on reproduction. J Obstet Gynaecol Res. 2019; 45: 951–60.
60. Cicinelli E., Bettocchi S., de Ziegler D., et al. Chronic endometritis, a common disease hidden behind endometrial polyps in premenopausal women: First evidence from a case-control study. J Minim Invasive Gynecol. 2019; 26: 1346–50.
61. Pirtea P., Cicinelli E., De Nola R., de Ziegler D., Ayoubi J.M. Endometrial causes of recurrent pregnancy losses: endometriosis, adenomyosis, and chronic endometritis. Fertil Steril. 2021; 115: 546–60.
62. Morimune A., Kimura F., Nakamura A., et al. The effects of chronic endometritis on the pregnancy outcomes. Am J Reprod Immunol. 2021; 85: e13357.
63. Salker M.S., Nautiyal J., Steel J.H., et al. Disordered IL-33/ST2 activation in decidualizing stromal cells prolongs uterine receptivity in women with recurrent pregnancy loss. PLoS One. 2012; 7: e52252.
64. Huang J.-Y., Su M., Lin S.-H., Kuo P.-L. A genetic association study of NLRP2 and NLRP7 genes in idiopathic recurrent miscarriage. Hum Reprod. 2013; 28: 1127–34.
65. Kuroda K., Venkatakrishnan R., James S., et al. Elevated periimplantation uterine natural killer cell density in human endometrium is associated with impaired corticosteroid signaling in decidualizing stromal cells. J Clin Endocrinol Metab. 2013; 98: 4429–37.
66. Kuroda K., Venkatakrishnan R., Salker M.S., et al. Induction of 11p-HSD 1 and activation of distinct mineralocorticoid receptor- and glucocorticoid receptor-dependent gene networks in decidualizing human endometrial stromal cells. Mol Endocrinol. 2013; 27: 192–202.
67. Guo W., Li P.F., Zhao G.F., Fan H.Y., Hu Y.L., Hou Y.Y. Glucocorticoid receptor mediates the effect of progesterone on uterine natural killer cells. Am J Reprod Immunol. 2012; 67: 463–73.
68. Szekeres-Bartho J., Balasch J. Progestagen therapy for recurrent miscarriage. Hum Reprod Update. 2008; 14: 27–35.
69. Coomarasamy A., Williams H., Truchanowicz E., et al. A randomized trial of progesterone in women with recurrent miscarriages. N Engl J Med. 2015; 373: 2141–8.
70. Saccone G., Schoen C., Franasiak J.M., Scott R.T. Jr, Berghella V. Supplementation with progestogens in the first trimester of pregnancy to prevent miscarriage in women with unexplained recurrent miscarriage: a systematic review and meta-analysis of randomized, controlled trials. Fertil Steril. 2017; 107: 430–8.e3.
71. Carp H.J. Progestogens in the prevention of miscarriage. Horm Mol Biol Clin Investig. 2016; 27: 55–62.